Glycyrrhetinic acid is a versatile chemical compound derived from glycyrrhizin, a natural sweetener found in licorice roots. Glycyrrhetinic acid's pharmacological properties have garnered significant attention in recent years due to its diverse range of potential applications. Researchers have also explored modifications of its chemical structure to create analogs with enhanced pharmacological effects, particularly in the context of cancer drug development. Despite its promising properties, it's essential to use glycyrrhetinic acid-containing products cautiously and under the guidance of healthcare professionals when necessary, as excessive consumption can lead to adverse effects.
The lambda max (λmax) of Glycyrrhetinic acid, which represents the wavelength at which it absorbs light most strongly, typically falls in the ultraviolet (UV) range. However, the specific λmax value may vary depending on factors such as the solvent used for measurement and the experimental conditions. In general, Glycyrrhetinic acid may have λmax values in the range of approximately 200 to 280 nanometers (nm) in the UV spectrum. To obtain the exact λmax value for a particular sample of Glycyrrhetinic acid, it would be necessary to perform UV-visible spectroscopy or consult scientific literature or databases that provide spectroscopic data for this compound under specific conditions.
Glycyrrhetinic acid, a hydrolytic product of glycyrrhizic acid, is a component of licorice with a molecular formula of C30H46O4. It is a pentacyclic triterpenoid, which means it consists of five interconnected carbon rings. Here is a breakdown of the elements and functional groups that Glycyrrhetinic acid contains: Carbon (C): Glycyrrhetinic acid contains 30 carbon atoms, which form the backbone of the molecule. Hydrogen (H): It contains 46 hydrogen atoms, primarily bonded to carbon atoms. Oxygen (O): Glycyrrhetinic acid contains 4 oxygen atoms, which are typically found in functional groups such as hydroxyl (-OH) and carboxyl (-COOH) groups.
Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients.
Glycyrrhetinic acid induces G1-phase cell cycle arrest in human non-small cell lung cancer cells through endoplasmic reticulum stress pathway.